Parkman Healthcare Partners LLC Cuts Position in Oscar Health, Inc. (NYSE:OSCR)

Parkman Healthcare Partners LLC trimmed its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 50.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 125,000 shares of the company’s stock after selling 125,000 shares during the quarter. Parkman Healthcare Partners LLC’s holdings in Oscar Health were worth $1,680,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in OSCR. JPMorgan Chase & Co. increased its stake in shares of Oscar Health by 348.7% during the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after buying an additional 8,051,379 shares during the period. BIT Capital GmbH increased its stake in shares of Oscar Health by 5,711.6% during the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock worth $60,129,000 after buying an additional 4,396,872 shares during the period. Deerfield Management Company L.P. Series C increased its stake in shares of Oscar Health by 50.7% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock worth $159,062,000 after buying an additional 3,983,325 shares during the period. Hennessy Advisors Inc. increased its stake in shares of Oscar Health by 550.3% during the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after buying an additional 3,544,300 shares during the period. Finally, Gilder Gagnon Howe & Co. LLC increased its stake in shares of Oscar Health by 51.4% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock worth $85,154,000 after buying an additional 2,151,256 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Price Performance

OSCR stock opened at $16.90 on Wednesday. The company has a market capitalization of $4.23 billion, a P/E ratio of -844.58 and a beta of 1.75. Oscar Health, Inc. has a twelve month low of $11.20 and a twelve month high of $23.79. The business has a 50 day simple moving average of $13.37 and a 200-day simple moving average of $14.63. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The business had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. During the same period in the prior year, the company earned $0.62 earnings per share. The company’s revenue was up 42.2% compared to the same quarter last year. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price target for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $20.08.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.